Reclassification of genetic variants in children with long QT syndrome
Open Access
- 8 May 2020
- journal article
- research article
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 8 (9) , e1300
Abstract
Background: Genes encoding cardiac ion channels or regulating proteins have been associated with the inherited form of long QT syndrome (LQTS). Complex pathophysiology and missing functional studies, however, often bedevil variant interpretation and classification. We aimed to evaluate the rate of change in variant classification based on current interpretation standards and dependent on clinical findings.Methods: Medical charts of children with a molecular genetic diagnosis of LQTS presenting at our centers were retrospectively reviewed. Reinterpretation of originally reported variants in genes associated with LQTS was performed based on current knowledge (March 2019) and according to the “Standards and Guidelines for the Interpretation of Sequence Variants” by the ACMG 2015.Results: About 84 distinct (likely) pathogenic variants identified in 127 patients were reinterpreted. In 12 variants (12/84, 14.3%), classification changed from (likely) pathogenic to variant of unknown significance (VUS). One of these variants was a hypomorphic allele escaping the standard variant classification. Individuals with variants that downgraded to VUS after reevaluation showed significantly lower Schwartz scores and QTc intervals compared to individuals with unchanged variant characterization.Conclusion: This finding confirms genetic variant interpretation as a dynamic process and underlines the importance of ongoing genetic counseling, especially in LQTS patients with minor clinical criteria.Keywords
This publication has 24 references indexed in Scilit:
- An International, Multicentered, Evidence-Based Reappraisal of Genes Reported to Cause Congenital Long QT SyndromeCirculation, 2020
- Recommendations for interpreting the loss of function PVS1 ACMG/AMP variant criterionHuman Mutation, 2018
- Using the genome aggregation database, computational pathogenicity prediction tools, and patch clamp heterologous expression studies to demote previously published long QT syndrome type 1 mutations from pathogenic to benignHeart Rhythm, 2018
- Classification and Reporting of Potentially Proarrhythmic Common Genetic Variation in Long QT Syndrome Genetic TestingCirculation, 2018
- Molecular Pathophysiology of Congenital Long QT SyndromePhysiological Reviews, 2017
- Large-scale mutational analysis of Kv11.1 reveals molecular insights into type 2 long QT syndromeNature Communications, 2014
- Genotype- and Phenotype-Guided Management of Congenital Long QT SyndromeCurrent Problems in Cardiology, 2013
- An In Vivo Cardiac Assay to Determine the Functional Consequences of Putative Long QT Syndrome MutationsCirculation Research, 2013
- Risk for Life-Threatening Cardiac Events in Patients With Genotype-Confirmed Long-QT Syndrome and Normal-Range Corrected QT IntervalsJACC, 2011
- Molecular characterization of two founder mutations causing long QT syndrome and identification of compound heterozygous patientsAnnals of Medicine, 2006